4th Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Support FDA user fee programs and review process consistency and predictability.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Environment/Superfund ENV

Support Consumer and Fuel Retailer Choice Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax. Support extension of R&D tax credit. Support protection of Orphan Drug Tax Credit.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Copyright/Patent/Trademark CPT

Address concerns with provisions of patent litigation reform, including inter partes review. Educate on Bayh-Dole Act "march-in" provision.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Support repeal of Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support creation of improved payment pathway for novel and breakthrough medical devices.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Support NIH research funding. Support implementation of 21st Century Cures Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.